Blue Owl Capital Holdings’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Blue Owl Capital Holdings’s Portfolio SLXNW Stock Details SLXNW Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$375	Buy
2024 Q4	–	Sell
2024 Q3	$396	Buy